These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12598014)

  • 1. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype.
    Bohlmeyer TJ; Helmke S; Ge S; Lynch J; Brodsky G; Sederberg JH; Robertson AD; Minobe W; Bristow MR; Perryman MB
    Cardiovasc Pathol; 2003; 12(1):23-31. PubMed ID: 12598014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
    Jiang Y; Habibollah S; Tilgner K; Collin J; Barta T; Al-Aama JY; Tesarov L; Hussain R; Trafford AW; Kirkwood G; Sernagor E; Eleftheriou CG; Przyborski S; Stojković M; Lako M; Keavney B; Armstrong L
    Stem Cells Transl Med; 2014 Apr; 3(4):416-23. PubMed ID: 24591732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome.
    Ricci M; Xu Y; Hammond HL; Willoughby DA; Nathanson L; Rodriguez MM; Vatta M; Lipshultz SE; Lincoln J
    PLoS One; 2012; 7(1):e29784. PubMed ID: 22299024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome.
    Kobayashi J; Yoshida M; Tarui S; Hirata M; Nagai Y; Kasahara S; Naruse K; Ito H; Sano S; Oh H
    PLoS One; 2014; 9(7):e102796. PubMed ID: 25050861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Genetic Landscape of Hypoplastic Left Heart Syndrome.
    Yagi H; Liu X; Gabriel GC; Wu Y; Peterson K; Murray SA; Aronow BJ; Martin LJ; Benson DW; Lo CW
    Pediatr Cardiol; 2018 Aug; 39(6):1069-1081. PubMed ID: 29569026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts.
    Verma SK; Deshmukh V; Nutter CA; Jaworski E; Jin W; Wadhwa L; Abata J; Ricci M; Lincoln J; Martin JF; Yeo GW; Kuyumcu-Martinez MN
    Sci Rep; 2016 Aug; 6():30896. PubMed ID: 27485310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell modelling of HLHS underlines the contribution of dysfunctional NOTCH signalling to impaired cardiogenesis.
    Yang C; Xu Y; Yu M; Lee D; Alharti S; Hellen N; Ahmad Shaik N; Banaganapalli B; Sheikh Ali Mohamoud H; Elango R; Przyborski S; Tenin G; Williams S; O'Sullivan J; Al-Radi OO; Atta J; Harding SE; Keavney B; Lako M; Armstrong L
    Hum Mol Genet; 2017 Aug; 26(16):3031-3045. PubMed ID: 28521042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome.
    Yagi H; Xu X; Gabriel GC; Lo C
    Adv Exp Med Biol; 2024; 1441():947-961. PubMed ID: 38884763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis.
    Hrstka SC; Li X; Nelson TJ;
    Stem Cells; 2017 Apr; 35(4):1106-1119. PubMed ID: 28142228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of MYH6 variants in hypoplastic left heart syndrome.
    Tomita-Mitchell A; Stamm KD; Mahnke DK; Kim MS; Hidestrand PM; Liang HL; Goetsch MA; Hidestrand M; Simpson P; Pelech AN; Tweddell JS; Benson DW; Lough JW; Mitchell ME
    Physiol Genomics; 2016 Dec; 48(12):912-921. PubMed ID: 27789736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in extra-cellular matrix and myocyte homeostasis between the neonatal right ventricle in hypoplastic left heart syndrome and truncus arteriosus.
    Davies B; d'Udekem Y; Ukoumunne OC; Algar EM; Newgreen DF; Brizard CP
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):738-44. PubMed ID: 18757206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription repression and blocks in cell cycle progression in hypoplastic left heart syndrome.
    Gambetta K; Al-Ahdab MK; Ilbawi MN; Hassaniya N; Gupta M
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2268-75. PubMed ID: 18344372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed myocardial connexin 43 and N-cadherin expressions in hypoplastic left heart syndrome and borderline left ventricle.
    Mahtab EA; Gittenberger-de Groot AC; Vicente-Steijn R; Lie-Venema H; Rijlaarsdam ME; Hazekamp MG; Bartelings MM
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1315-22. PubMed ID: 22405962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation.
    Gaber N; Gagliardi M; Patel P; Kinnear C; Zhang C; Chitayat D; Shannon P; Jaeggi E; Tabori U; Keller G; Mital S
    Am J Pathol; 2013 Sep; 183(3):720-34. PubMed ID: 23871585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-RNA expression in hypoplastic left heart syndrome.
    Sucharov CC; Sucharov J; Karimpour-Fard A; Nunley K; Stauffer BL; Miyamoto SD
    J Card Fail; 2015 Jan; 21(1):83-8. PubMed ID: 25291457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome.
    Miyamoto SD; Stauffer BL; Polk J; Medway A; Friedrich M; Haubold K; Peterson V; Nunley K; Nelson P; Sobus R; Stenmark KR; Sucharov CC
    J Heart Lung Transplant; 2014 Aug; 33(8):785-93. PubMed ID: 24793904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective.
    Crucean A; Alqahtani A; Barron DJ; Brawn WJ; Richardson RV; O'Sullivan J; Anderson RH; Henderson DJ; Chaudhry B
    Orphanet J Rare Dis; 2017 Aug; 12(1):138. PubMed ID: 28793912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration and validation of hub genes and pathways in the progression of hypoplastic left heart syndrome via weighted gene co-expression network analysis.
    Liu X; Shang H; Li B; Zhao L; Hua Y; Wu K; Hu M; Fan T
    BMC Cardiovasc Disord; 2021 Jun; 21(1):300. PubMed ID: 34130651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6q25.1 (TAB2) microdeletion is a risk factor for hypoplastic left heart: a case report that expands the phenotype.
    Cheng A; Neufeld-Kaiser W; Byers PH; Liu YJ
    BMC Cardiovasc Disord; 2020 Mar; 20(1):137. PubMed ID: 32183715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac regenerative capacity is age- and disease-dependent in childhood heart disease.
    Traister A; Patel R; Huang A; Patel S; Plakhotnik J; Lee JE; Medina MG; Welsh C; Ruparel P; Zhang L; Friedberg M; Maynes J; Coles J
    PLoS One; 2018; 13(7):e0200342. PubMed ID: 30044800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.